Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Juan Lv
Institution:
First Hospital of Jilin University
Observed institutions:
Jilin University,
Fudan University,
Kunming Medical University,
First Hospital of Jilin University,
State Key Laboratory of Genetic Engineering
ORCID:
0009-0008-0463-6010
Observed ORCID:
0009-0008-0463-6010
OpenAlex ID:
A5082458425
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A
2015
·
Chen Yang
, Xinhao Zhao
, et al.
·
Cellular and Molecular Immunology
·
102
Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD
2019
·
Hui Zhang
, Hongqin Xu
, et al.
·
Scientific Reports
·
30
PDF
Factors Associated with Spontaneous Clearance of Hepatitis C Virus in Chinese Population
2014
·
Fei Kong
, Yu Pan
, et al.
·
BioMed Research International
·
30
PDF
Hsa‐miR‐196a2 Functional SNP is Associated With Severe Toxicity After Platinum‐Based Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients in a Chinese Population
2012
·
Xiaoying Zhan
, Wenting Wu
, et al.
·
Journal of Clinical Laboratory Analysis
·
30
PDF
CXC chemokine IP-10: a key actor in liver disease?
2013
·
Lin-Jiao Chen
, Juan Lv
, et al.
·
Hepatology International
·
28
The association of hepatitis c virus infection status with serum glucose levels
2019
·
Yinping Li
, Xiaomei Wang
, et al.
·
BMC Gastroenterology
·
15
PDF
Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China
2015
·
Hongqin Xu
, Ge Yu
, et al.
·
BMC Public Health
·
14
PDF
Immune-relevant genes of systemic lupus erythematosus by transcriptome profiling analysis
2022
·
Juan Lv
, Lu Chen
, et al.
·
Cytokine
·
9
Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients
2013
·
Haibo Sun
, Juan Lv
, et al.
·
Experimental Biology and Medicine
·
9
Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients
2012
·
Juan Lv
, Qinglong Jin
, et al.
·
Mediators of Inflammation
·
9
PDF
Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
·
Clinical Cancer Research
·
8
PDF
Renoprotective anti-CD45RB antibody induces B cell production in systemic lupus erythematosus based on single-cell RNA-seq analysis
2022
·
Juan Lv
, Lu Chen
, et al.
·
Journal of Autoimmunity
·
7
IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection
2016
·
Ruihong Wu
, Xiumei Chi
, et al.
·
Infection Genetics and Evolution
·
7
PDF
CD 24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV ‐infected Chinese population
2014
·
Haibo Sun
, Yu Pan
, et al.
·
Liver International
·
7
Sustained viral response and treatment‐induced cytopenia correlate with SLC s and KLF12 genotypes in interferon/ribavirin‐treated Chinese chronic hepatitis C patients
2016
·
Ruqi Mei
, Xiumei Chi
, et al.
·
Journal of Gastroenterology and Hepatology
·
4
PDF
Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis
2023
·
Zhi Li
, Li Jia
, et al.
·
Cancer Genomics & Proteomics
·
3
PDF
HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection
2026
·
Zhengmin Wang
, Nan Liu
, et al.
·
Gut
Data from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Data from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Figure S2 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Figure S4 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Figure S4 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Figure S3 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Table S9 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Supplementary Table S8 from Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics
2024
·
Xiaoqi Peng
, Hongbo Zhao
, et al.
Show more works
View as search
Works count:
39
Citation count:
312
H-index:
9
I10-index:
7
Year
Topic
Type